Paper
Raluca Csernatoni, Alicia Wanless
{
"authors": [
"Raluca Csernatoni"
],
"type": "legacyinthemedia",
"centerAffiliationAll": "dc",
"centers": [
"Carnegie Endowment for International Peace",
"Carnegie Europe"
],
"collections": [],
"englishNewsletterAll": "ctw",
"nonEnglishNewsletterAll": "",
"primaryCenter": "Carnegie Europe",
"programAffiliation": "EP",
"programs": [
"Europe"
],
"projects": [],
"regions": [
"Europe",
"Western Europe",
"Iran"
],
"topics": [
"Security",
"Technology"
]
}
REQUIRED IMAGE
In The Media
Beyond Autonomy: Rethinking Europe as a Strategic Actor
Rather than pursuing buzzwords like strategic autonomy, European leaders should balance home-grown initiatives with an openness to trade and investment in a harmonious and comprehensive manner.
Published on Feb 7, 2022
About the Author
Raluca Csernatoni
Fellow, Carnegie Europe
Raluca Csernatoni is a fellow at Carnegie Europe, where she specializes on European security and defense, as well as emerging disruptive technologies.
- Assessing Information Ecosystems: How Governments Can Get Ahead of Hybrid Threats
- When AI Agents Attack: Autonomous Cyber Operations and Europe’s Governance GapPaper
Raluca Csernatoni, Patryk Pawlak
Recent Work
Carnegie does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.
More Work from Carnegie Endowment for International Peace
- We Need Ongoing Monitoring of AI and Political InformationArticle
Monitoring is essential so that policymakers and the public can understand—and have a say in—how AI systems affect politics.
Danaé Metaxa , Alex Engler
- The Two Logics Driving Japan’s Security PolicyArticle
Japan’s revision of its three strategic documents reflects an intention to keep the United States engaged in the region while Japan fills any vacuums of U.S. power to preserve the Indo-Pacific order.
Ryo Sahashi
- Caught in the Middle: Chinese Biotech Firms’ Divergent Responses to U.S. SanctionsCommentary
Chinese biotech companies have been on the receiving end of U.S. economic coercion. Yet their responses have differed significantly because firm and state interests are not uniformly aligned. For Washington, treating all Chinese tech firms the same, irrespective of their actual interests, risks pushing them farther into Beijing’s corner.
Xue Gong
- Inside the Global Race to Erode a Battery Manufacturing MonopolyCommentary
Over the past decade, China has moved from marginal player to major producer of all things batteries. The United States, Europe, and others are aiming to balance the market.
Milo McBride
- Why Korea’s President Skipped Washington for Silicon Valley and BrasíliaCommentary
Lee’s tour shows how Seoul is reorganizing its diplomacy away from Pyongyang and toward industrial networks and the geography of the compute economy.
Darcie Draudt-Véjares
